These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 21070842)

  • 1. Oral drug delivery in personalized medicine: unmet needs and novel approaches.
    Wening K; Breitkreutz J
    Int J Pharm; 2011 Feb; 404(1-2):1-9. PubMed ID: 21070842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel delivery device for monolithical solid oral dosage forms for personalized medicine.
    Wening K; Breitkreutz J
    Int J Pharm; 2010 Aug; 395(1-2):174-81. PubMed ID: 20635515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V; Musakhanian J; Marchaud D
    Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract.
    Weitschies W; Blume H; Mönnikes H
    Eur J Pharm Biopharm; 2010 Jan; 74(1):93-101. PubMed ID: 19619649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AC biosusceptometry in the study of drug delivery.
    Corá LA; Romeiro FG; Stelzer M; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Adv Drug Deliv Rev; 2005 Jun; 57(8):1223-41. PubMed ID: 15935871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral films: Current status and future perspectives: I - Galenical development and quality attributes.
    Borges AF; Silva C; Coelho JF; Simões S
    J Control Release; 2015 May; 206():1-19. PubMed ID: 25747406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric drug formulations: a review of challenges and progress.
    Ivanovska V; Rademaker CM; van Dijk L; Mantel-Teeuwisse AK
    Pediatrics; 2014 Aug; 134(2):361-72. PubMed ID: 25022739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of microbial contamination and dosing accuracy of oral dispensers.
    Dockhorn S; Feuersenger D; Schuenemann S; Knauf B; Duerr S; Schubert-Zsilavecz M; Abdel-Tawab M
    J Clin Pharm Ther; 2010 Jun; 35(3):279-87. PubMed ID: 20831530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing early formulations: practice and perspective.
    Li P; Zhao L
    Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microchips and controlled-release drug reservoirs.
    Staples M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):400-17. PubMed ID: 20564466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral pulsatile delivery: rationale and chronopharmaceutical formulations.
    Maroni A; Zema L; Del Curto MD; Loreti G; Gazzaniga A
    Int J Pharm; 2010 Oct; 398(1-2):1-8. PubMed ID: 20655998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral dosage forms and drug delivery systems: tablets, oral films, liquid dosage forms, oral bioavailability enhancement.
    Alany R
    Pharm Dev Technol; 2017 Mar; 22(2):137. PubMed ID: 28178908
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives.
    Roy P; Shahiwala A
    J Control Release; 2009 Mar; 134(2):74-80. PubMed ID: 19105973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in oral transmucosal drug delivery.
    Patel VF; Liu F; Brown MB
    J Control Release; 2011 Jul; 153(2):106-16. PubMed ID: 21300115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan: a unique polysaccharide for drug delivery.
    Felt O; Buri P; Gurny R
    Drug Dev Ind Pharm; 1998 Nov; 24(11):979-93. PubMed ID: 9876553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal drug delivery.
    Guy RH
    Handb Exp Pharmacol; 2010; (197):399-410. PubMed ID: 20217537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering caregiver concerns: 5 key issues that still remain unresolved in administration of oral medicines for children in India.
    Talegaonkar S; Chitlangia A; Pradhan V; More S; Salunke S
    Eur J Pharm Biopharm; 2023 Jun; 187():166-174. PubMed ID: 36965592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.